chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient requested to receive her second dose one day early due to her going out of the country and will be unable to receive her second dose within the 4-6 week period after her first dose. Confirmed with patient that there was no other time she could come in for her second dose on/after the 28th day before her trip.
pt recvd vax; T 105;tempra given but fever only went down sl;
was given MENACTRA 8/8/07 but was not noted in medical record. Pt seen 7/28/08 given MENACTRA again. No adverse event reported by patient or parents
Immediately after receiving the injection, I felt pain/sore that traveled from the injection site, went through and across my left pectoral and ended at center of my chest/heart area.  I waited 15 minutes in the observation area to see if symptoms would get worse, but they did not; and so I left the facility and drove home.  On my way home, about 45 minutes after receiving the shot, I felt my throat tightening up a bit, and my left hand and eyelids began to cramp up.  I stopped at a pharmacy and bought some Benadryl.  After 30 minutes, the pain in my chest began to feel better, and the cramping had disappeared.  At about 6 pm that same day, my chest pain returned; and so I took one more Benadryl.  The pain/soreness began to disappear after about 30 minutes.  I felt fine for exactly two weeks.  On Thursday, April 1st, I woke up with severe abdominal pain, diarrhea, and constant vomiting for about 12 hours.  Went to urgent care and received an anti-nausea shot.  The vomiting stopped, but the abdominal pain continued until the next morning.  The weekend of April 10th, I experienced the chest pain again.  This time it was very concerning because I felt very lightheaded, short of breath and faint.  I checked myself into ER two days after.
injection site-warmth, tenderness, aches that lasted 2 days after injection. Resolved without intervention. Joint stiffness in pinky and ring fingers of both hands. Symptoms most severe the 2 days after injection. Joints are still stiff in the a.m. 7 days after the injection.
pt recvd vax;on 06oct95 exp n,v,severe HA & dizziness; seen in er & was hosp til 14oct95;
SLIGHT HEADACHE; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. The patient's past medical history included headache, and concurrent conditions included allergy, and other pre-existing medical conditions included none. The patient's height, and weight were not reported. The patient's concurrent conditions included headache, and other pre-existing medical conditions included none.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry date: unknown) dose was not reported, administered on 23-MAR-2021 around 16:30 or 17:00 to left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced slight headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from slight headache. This report was non-serious.    s.
my husband's ex-wife died; This is a spontaneous report from a contactable consumer. This consumer reported that a female patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter stated that her husband's ex-wife died. It was unknown if Autopsy Done. The outcome of the event was fatal.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Reported Cause(s) of Death: my husband's ex-wife died
I am reporting these symptoms in the hopes it helps others.  Injection site pain and swelling  started 3 hours after injection and lasted  4 days, minor pain now if press on muscle.  Beginning 4/11 until present tiredness, no energy, minor difficulty concentrating and remembering how to say things.  I thought at first needed good night sleep, it gets worse towards end of the day.   Beginning 4/14  muscle pain began on my lower back and began to move up as the day progressed, became uncomfortable to sit for more than 1 hour.   Over weekend extended to legs and neck. On 4/19, Monday night 6:30pm  muscle pain over all body,  slight headache that comes and goes more annoying then anything, feeling a little warmer than usual, no fever.  There is no muscle pain if I do not move.  I'm resting, in bed, drinking water, appetite not affected.  I am scheduled for the second dose on 4/30 .  May this information be helpful.  Thanks!
6 days after her first dose, she developed a rash on her knee. It was swollen and painful.we didn?t realize it was related until she developed a similar rash after her second dose. 4 days after her second dose she developed a rash on her left arm and hands. Looked the same as the one she had on her knee- raised, swollen and her arm hurt.
Shingrix administered after temperature excursion; This case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK Receipt Date: 29-SEP-2022 Reporter's Comment: The registered pharmacist reported that the patient received a dose of Shingrix vaccine, and which was exposed down to 28 Fahrenheit for 8 hours. The reporter stated that there were no prior excursions. The reporter asked about Shingrix stability and wanted to know any recommendation on revaccination. The reporter was unable to provide any vaccine or patient details at this moment. The reporter did not consent to follow up. Additional supportive information: The patient received a dose of Shingrix vaccine, and which was exposed down to 28 Fahrenheit for 8 hours, which led to incorrect storage of drug. This case was one of 8 cases reported by same reporter.; Sender's Comments:  US-GSK-US2022140235:Same reporter US-GSK-US2022140227:Same reporter US-GSK-US2022140234:Same reporter US-GSK-US2022140237:Same reporter US-GSK-US2022140239:Same reporter US-GSK-US2022140240:Same reporter US-GSK-US2022140241:Same reporter
Within 5 mins of receiving HPV injection pt became pale, lightheaded, vision became black, diaphoretic. Had pt wheeled to obs. room- monitored pt for 20 min - full recovery - discharged to Mom care.
Cold chills, extreme fatigue, very sleepy, slight headache, and all my joints ached.
Horrible chills, severe weakness, sweating, headache -- had to leave work, could not get up from bed without assistance, had difficulty sitting up -- lasted until during that night when I woke up the next morning I was much improved and returned to work  Soreness at the injection site and through the upper arm on that side, minor headache, minor fatigue -- continues and is much the same as after other vaccinations such as the flu vaccine
Patient outreach event. Received an adult dose of Hep A. The vaccines were stored in an electric portable cooler. The Hep A adult was stored in the wrong section and paramedic student administering the dose did not see it was a large dose.
approx 24hr p/vax to lt arm pt had severe swelling w/color, edema, induration & tenderness to upper arm around site;
Pain in arm; Shoulders are aching; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and ARTHRALGIA (Shoulders are aching) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A, 006B21A and 027A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS), LOSARTAN, MULTIVITAMIN [VITAMINS NOS], COLECALCIFEROL (VITAMIN D3), CALCIUM and MAGNESIUM for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and ARTHRALGIA (Shoulders are aching). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in arm) and ARTHRALGIA (Shoulders are aching) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 23-Nov-2021: Follow up contains No New Information.
Adverse drug reactions (including pain) after human papillomavirus (HPV) vaccine; Adverse drug reactions (including pain) after human papillomavirus (HPV) vaccine; product origin unk; This spontaneous social media report was received from an other health professional and refers to a female patients in age between 12 to 24 years old. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On an unknown date, the patient was vaccinated with human papillomavirus (HPV) vaccine (manufacturer unknown) (dose, route of administration, lot #, expiration date were not reported) for prophylaxis. On unknown day, the patient experienced undesirable drug effects (including pain). The outcomes of the events were not reported.  The events were considered as related to human papillomavirus (HPV) vaccine (manufacturer unknown).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2107USA008727: US-009507513-2107USA008728: US-009507513-2107USA008733: US-009507513-2107USA008729: US-009507513-2107USA008732: US-009507513-2107USA008731: US-009507513-3107USA008730:
mom noticed urticarial reaction in Am following vax the prev day reaction all over body x/face; controlled w/DPH;
Patient starting getting an itchy rash on 7/4/23. Rash is on forearms and neck is also itching.
pt recv vax and shortly p/vax died;MD does not feel that the shot contributed to death;pt recv flu vax in past w/no adverse effects;COD MI;
The patient woke up at 4:00 am on 06/19/2001 and had a seizure. The patient's fever was 101.4F. The mother of the patient states the seizure lasted 5 minutes. The patient was treated at the ER with Advil and received a prescription for Amoxicillin to treat an ear infection. The patient was referred to a neurologist.
Seen at the ER for c/o SOB and cough for 1 week.  Initial Covid in ER negative.  Admitted to ward bed on 2/22/23 with Dx of pneumonia, hypoxemia, COPD to the care of the hospitalist.  On 2/23/23 patient was found unresponsive and CPR was started.  Patient was transferred to the ICU and placed on a ventilator.  Second Covid test was found to be positive.  On 2/24/23 patient was transferred to another hospital for higher level of care.
This spontaneous case reported by a consumer, describes the occurrence of product dose omission issue (second dose of vaccine deferred) and exposure to SARS-CoV-2 (exposure to COVID-19 positive patient) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 037K20A) for COVID-19 immunization. No medical history reported. On Jan 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 29, 2021, patient experienced product dose omission issue (second dose of vaccine deferred). On an unknown date, patient experienced exposure to SARS-CoV-2 (exposure to COVID-19 positive patient). At the time of the report, product dose omission issue (second dose of vaccine deferred) outcome: unknown; and exposure to SARS-CoV-2 (exposure to COVID-19 positive patient) resolved. Patient not tested for COVID-19, but still told to quarantine since wife tested positive. No additional information could be obtained regarding patient. Sender's comments: This case linked (cross-linked ID) to MOD21-083977 (E2B linked report).
This spontaneous report was received from a physician assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies was reported. On an unknown date "over a year ago", the patient was vaccinated with the first dose of GARDASIL (strength, dose, route of administration, anatomical location, lot # and expiration date were not provided). At the time of the report (reported as "now"), the patient would like to received a second dose of GARDASIL (inappropriate schedule of vaccine administration). No adverse symptoms were reported. Additional information has been requested.
Pt. very upset after immunization. Large area of red, non papular, petechiae under chin and clavicle appeared immediately after immunization. Examined by Dr. in clinic.
LEFT EYE WITH BLOOD SPOT IN THE EYEBALL; PAIN IN THE CENTRAL PART OF THE CHEST; DIFFICULTY BREATHING WHEN DOING  ACTIVITIES; HEADACHE; LEFT ARM PAIN WHERE SHOT WAS ADMINISTERED; COULDNT SLEEP THE DAY OF THE VACCINE; BODY TREMBLING; This spontaneous report received from a 48-year-old, male patient The patient's weight was 184 pounds, and height was 74 inches. The patient's past medical history included gallbladder removal. The patient was non-smoker, social drinker (only in holidays mostly), and the patient had no known allergies. The patient did not have any drug abuse or illicit drug use.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 207A21A and expiry: 23-JUN-2021) dose was not reported, 1 total administered on 14-MAY-2021 around 13:15 to left arm for prophylactic vaccination.  No concomitant medications were reported.  On 14-MAY-2021, the patient experienced left arm pain where shot was administered, body trembling and couldn't sleep on the day of vaccine. On 17-MAY-2021, the patient experienced headache which had diminished, but suddenly they were like stabbing, left eye with blood spot in the eyeball and pain in the central part of the chest, which on occasions varies from right to left with breathing difficulty when doing activities.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body trembling, couldn't sleep, and left arm pain where shot was administered on 18-MAY-2021, was recovering from headache, and left eye with blood spot in the eyeball, and had not recovered from pain in the central part of the chest, and difficulty breathing when doing activities. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 : 20210555889-COVID-19 VACCINE AD26.COV2.S -Left eye with blood spot in the eye ball. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Moderna COVID-19 Vaccine EUA  48 hours of fever, chills, fatigue, aches, nausea.  48+ hours of arm pain, swelling, stiffness, and immobility. I still cannot lift my left arm past 90 degrees from my side. I can not reach across or behind my body with my left arm. I cannot lift any significant weight using my left shoulder.
Had an unexpected and unusual reaction to the PPD test. Symptoms included increased erythema, tenderness, and a nodule. It is suspected that a 0.1 ml of anthrax vaccine was erroneously administered to the patient instead of the standard PPD solution.
LITTLE BIT SLEEPY; This spontaneous report received from a patient concerned a male of unspecified age, ethnic origin and race. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis.  On an unspecified date, the patient experienced little bit sleepy and fatigue (dose number in series 1). The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported and has been requested.  No concomitant medications were reported.  On an unspecified date, the patient was a little bit sleepy (dose number in series 2), the patient was feeling this way for 1 day.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from little bit sleepy. This report was non-serious. This case, involving the same patient is linked to 20221012790.
I contracted COVID-19 4/11/22 with symptoms of severe headache directly on top of the head, high blood pressure, shortness of breath, sweats, chest tightness, I also developed skin rash inside both elbows 1 week after illness and lasted 3 days. I was ill for 3 days and was feeling much better after that. Have lingering symptoms of shortness of breath and chest tightness. The arthritis in my right wrist and ankle pain accompanied by swelling has been flaring up to an extreme level for the last 2 weeks, which is out of the normal. I was prescribed Paxlovid with another antiviral and a medication to make it last longer.
I developed supra ventricular tachycardia with underlying atrial fibrillation; I developed supra ventricular tachycardia with underlying atrial fibrillation; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Aug2021 as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ATRIAL FIBRILLATION (medically significant), SUPRAVENTRICULAR TACHYCARDIA (non-serious) all with onset Sep2021, outcome "unknown" and all described as "I developed supra ventricular tachycardia with underlying atrial fibrillation".  Clinical course: The patient registered nurse for 5 years. There was no heart disease on patients mother or fathers side of the family. The patient received covid vaccine in Aug2021. Roughly a month later developed supra ventricular tachycardia with underlying atrial fibrillation.  The information on the batch/lot number for BNT162B2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information the reported serious event Atrial fibrillation is more likely an intercurrent or due to underlying medical condition.However the contributory role of the suspect product BNT162b2 cannot be excluded for the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Swelling and redness to the right thigh Area is hard and warm to touch. 6-7 cm area of erythema on right thigh. Central in this area is an area of induration Treated with Duricef 250 mg 15 ml 1 tsp PO BID x 10 days
pt recvd vax 29JUN89. On 07JUL89 pt devel urticarial rash.
Seen at Hospital for Shortness of breath. DX with viral Covid pneumonia. Seen in emergency room only.
I do feel little bit pressure when I am breathing; This is a spontaneous report from a contactable consumer (patient). This consumer reported for himself that:  The patient of an unspecified age and gender received second dose of bnt162b2 (COMIRNATY, solution for injection) (Batch/Lot Number: unknown) via an unspecified route of administration on 23Jun2021 at 11:00 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history included asthma and Obesity. Its not severe asthma but had asthma.(Further not clarified hence not captured in tab).  The concomitant medications were not reported. The historical vaccine included first dose of bnt162b2 (COMIRNATY, solution for injection) (Batch/Lot Number: unknown) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. Patient reported that received second dose of vaccine this morning about 10 hours ago. Patient was mostly being trying but he was also asthmatic and obese so patient had been experiencing some shortness of breath nothing too severe, but patient was just concerned about what time it would be a concern. Patient reported that from the last 2 hours or so patient had been little short of breath nothing too bad, patient could breath fine, but patient felt little bit pressure when breathing on 23Jun2021. The patient was asking was that a concern and should patient go to the ER. The outcome of the event was unknown.  Information on Batch/Lot number has been requested.
Still cant use my arm more that 80%, very hard to lift and extend. Arm extremely sore and gets tingly. Don't have full range of motion. Aches extend to neck, back.  Still extremely achy and edgy.  No appetite.
developing "hives" 36 hours post injection; This is a spontaneous report from a contactable pharmacist. A female patient (Age: 38; unit: unknown) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 08Jan2021 at a single dose for covid-19 immunization. Medical history included COVID-19 o 30Oct2020, developing "rashes anytime [she] gets ill" and she therefore believes that her reaction was her immune system's response. The patient's concomitant medications were not reported. The patient developed "hives" 36 hours post injection on Jan2021 with outcome of unknown. She asked if such "delayed" reaction was reported as a side effect of the vaccine. mentioned that she would like to receive the second dose, although her PCP is reluctant to it.  Information about Lot/Batch number has been requested.